Last updated: March 3, 2022
Sponsor: Nanjing First Hospital, Nanjing Medical University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Chest Pain
Congestive Heart Failure
Heart Failure
Treatment
N/AClinical Study ID
NCT05278026
ChiHFpEF-Cohort
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with CVD, defined as at least one diagnosis of coronary heart disease,hypertension, type 2 diabetes or cardiomyopathy. The definition of coronary heartdisease was stenosis of the main coronary arteries ≥ 50% using percutaneous coronaryangiography or coronary computed tomography angiography findings. The definition ofhypertension was systolic blood pressure ≥ 140 mmHg, diastolic blood pressure ≥ 90mmHg or pharmacological treatment. The definition of type 2 diabetes was fasting bloodglucose ≥ 7.0 mmol/L, random blood glucose ≥ 11.1 mmol/L and HbA1c > 6.5% or the orthe use of hypoglycaemic medications. Cardiomyopathy was defined as the presence ofcardiac insufficiency in patients with dilated cardiomyopathy suggested bypercutaneous coronary angiography or coronary CT angiography use of hypoglycaemicmedications.
Exclusion
Exclusion Criteria:
- primary diagnoses of atherosclerosis (stenosis of the main coronary arteries < 50%),congenital heart diseases, arrhythmia, lung diseases, aortic dissection, peripheralvascular diseases, pericardial diseases, myocarditis, hypertrophic cardiomyopathy,heart valvular diseases, cardiophobia, costal chondritis, shock, thyroid diseases,infection or concomitant liver or renal dysfunction.
Study Design
Total Participants: 2000
Study Start date:
January 01, 2014
Estimated Completion Date:
January 01, 2026
Study Description
Connect with a study center
Nanjing First Hospital
Nanjing, Jiangsu 210006
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.